Nebenwirkungen · Evenity
EVENITY 105 mg solution for injection in pre-filled pen EVENITY 105 mg solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 5–6
HOS-139548 · Präparat HOS-098368
5 Frequency MedDRA System Organ Class Adverse reaction category Nasopharyngitis Very common Infections and infestations Sinusitis Common Hypersensitivitya Common Rash Common Dermatitis Common Immune system disorders Urticaria Uncommon Angioedema Rare Erythema multiforme Rare Metabolism and nutrition disorders Hypocalcaemiab Uncommon Headache Common Nervous system disorders Strokec Uncommon Eye disorders Cataract Uncommon Cardiac disorders Myocardial infarctionc Uncommon Arthralgia Very common Musculoskeletal and connective tissue Neck pain Common disorders Muscle spasms Common General disorders and administration site Injection site reactionsd Common conditions a. See sections 4.3 and 4.4. b. Defined as albumin adjusted serum calcium that was below the lower limit of normal. See sections 4.3 and 4.4. c. See section “Myocardial infarction and stroke” below. d. Most frequent injection site reactions were pain and erythema.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-07T15:31:00Z · SHA-256 350bccbdb1daac02b4a8386e742b9e66b7f3704c090c59a51d1856d298cfde74 · Passage fcedd8bfcc46440073b983cfef92428088f814c89eebdac5887e14585cba8457 · Zeichen 964–3507 im Abschnitt